| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/EVO.13041 |
| P8608 | Fatcat ID | release_qjavlaofbbcw5n4gnnqhsof6wa |
| P698 | PubMed publication ID | 27566611 |
| P50 | author | Matthieu Foll | Q30114358 |
| Jeffrey D. Jensen | Q40513972 | ||
| Claudia Bank | Q57548171 | ||
| Hyunjin Shim | Q57951020 | ||
| P2093 | author name string | Jennifer P Wang | |
| Konstantin B Zeldovich | |||
| Nicholas Renzette | |||
| Ping Liu | |||
| Robert W Finberg | |||
| Timothy F Kowalik | |||
| Daniel N A Bolon | |||
| Sebastian Matuszewski | |||
| P2860 | cites work | Approximate Bayesian computation | Q4781761 |
| The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase | Q21089768 | ||
| Quasispecies theory in the context of population genetics | Q21283965 | ||
| Evolutionary rescue: linking theory for conservation and medicine | Q26862297 | ||
| Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants | Q27650620 | ||
| Selforganization of matter and the evolution of biological macromolecules | Q28248277 | ||
| Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase | Q28387364 | ||
| Influenza virus drug resistance: a time-sampled population genetics perspective | Q28540172 | ||
| Influenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cells | Q28650894 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE | Q29616118 | ||
| Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir | Q30306773 | ||
| Adaptive strategies of the influenza virus polymerase for replication in humans | Q30383307 | ||
| In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses | Q30387420 | ||
| Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates | Q30393205 | ||
| Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission. | Q30421139 | ||
| T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro | Q30426020 | ||
| Detecting and Quantifying Changing Selection Intensities from Time-Sampled Polymorphism Data | Q31044574 | ||
| Evolution at a high imposed mutation rate: adaptation obscures the load in phage T7 | Q33628435 | ||
| Permissive secondary mutations enable the evolution of influenza oseltamivir resistance | Q34118992 | ||
| The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. | Q34119838 | ||
| Generation and characterization of influenza A viruses with altered polymerase fidelity | Q34137544 | ||
| Error catastrophe and antiviral strategy | Q34153584 | ||
| The evolution of stress-induced hypermutation in asexual populations | Q34285727 | ||
| Mutation induced extinction in finite populations: lethal mutagenesis and lethal isolation | Q34372268 | ||
| Favipiravir (T-705), a novel viral RNA polymerase inhibitor | Q34374652 | ||
| Global transmission of oseltamivir-resistant influenza | Q34955928 | ||
| Molecular determinants for nuclear import of influenza A PB2 by importin α isoforms 3 and 7. | Q35136748 | ||
| A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity | Q35163547 | ||
| WFABC: a Wright-Fisher ABC-based approach for inferring effective population sizes and selection coefficients from time-sampled data | Q35169864 | ||
| Phosphorylation controls the nuclear-cytoplasmic shuttling of influenza A virus nucleoprotein | Q35641136 | ||
| The effects of deleterious mutations on evolution at linked sites | Q35644757 | ||
| Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses | Q35666012 | ||
| Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry | Q36384462 | ||
| An overlapping protein-coding region in influenza A virus segment 3 modulates the host response | Q36554219 | ||
| Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus | Q36708487 | ||
| Controlling mutation: intervening in evolution as a therapeutic strategy | Q36961674 | ||
| Thinking too positive? Revisiting current methods of population genetic selection inference | Q38273399 | ||
| Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro | Q39071692 | ||
| The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. | Q40579225 | ||
| Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region | Q40852854 | ||
| Lethal mutagenesis and evolutionary epidemiology | Q40863246 | ||
| The mutational meltdown in asexual populations | Q41067565 | ||
| Mechanism of action of T-705 against influenza virus | Q41091905 | ||
| Favipiravir elicits antiviral mutagenesis during virus replication in vivo | Q41693281 | ||
| Theory of lethal mutagenesis for viruses | Q41979840 | ||
| On measuring selection in experimental evolution. | Q42076622 | ||
| Unbiased estimator for genetic drift and effective population size. | Q42591660 | ||
| Error thresholds and the constraints to RNA virus evolution | Q44997148 | ||
| Oseltamivir resistance--disabling our influenza defenses | Q46863506 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| P433 | issue | 11 | |
| P1104 | number of pages | 15 | |
| P304 | page(s) | 2470-2484 | |
| P577 | publication date | 2016-08-26 | |
| P1433 | published in | Evolution | Q4038411 |
| P1476 | title | An experimental evaluation of drug-induced mutational meltdown as an antiviral treatment strategy. | |
| P478 | volume | 70 |
| Q91595542 | Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy |
| Q91930483 | Destabilization of the human RED-SMU1 splicing complex as a basis for host-directed antiinfluenza strategy |
| Q47130579 | Experimental adaptation of human echovirus 11 to ultraviolet radiation leads to resistance to disinfection and ribavirin |
| Q63976719 | Influenza virus polymerase inhibitors in clinical development |
| Q58089563 | Mutations in influenza A virus neuraminidase and hemagglutinin confer resistance against a broadly neutralizing hemagglutinin stem antibody |
| Q40072274 | Resistance of Echovirus 11 to ClO2 Is Associated with Enhanced Host Receptor Use, Altered Entry Routes, and High Fitness |
| Q40064817 | The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution. |
| Q57799444 | The mechanism of resistance to favipiravir in influenza |
| Q55424984 | Two sides of the same coin: A population genetics perspective on lethal mutagenesis and mutational meltdown. |
Search more.